Login to Your Account



Stock Dented;; Shades Of Anadys?

Departure Of CEO No Cause For Panic, ArQule Reassures

By Randall Osborne


Monday, January 14, 2008
The 22 percent-plus hit taken last week by ArQule Inc. last week signaled investor jitters on word that Stephen Hill, president and CEO, is stepping down as of March. Analysts sought to calm Wall Street, but observers hardly required long memories to recall the June 2006 case of Anadys Pharmaceuticals Inc.
(BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription